Диссертация (1139535), страница 55
Текст из файла (страница 55)
Raymond D, Peterson E. A critical review of early-onset and late-onsetpreeclampsia. Obstet Gynecol Surv. 2011 Aug;66(8):497-506.273. Redman C. Pre-eclampsia: A complex and variable disease. PregnancyHypertens. 2014 Jul;4(3):241-2.339274. Redman CW, Sargent IL. Immunology of pre-eclampsia.
Am J ReprodImmunol. 2010 Jun;63(6): 534-43.275. Redman CW, Staff AC. Preeclampsia, biomarkers, syncytiotrophoblaststress, and placental capacity. Am J Obstet Gynecol. 2015 Oct;213(4 Suppl):S9.e1,S9-11.276. Ree PH, Hahn WB, Chang SW,Jung SH, Kang JH, Cha DH, Kang MS, HuhJY. Early detection of preeclampsia using inhibin a and other second-trimesterserum markers.
Fetal Diagn Ther. 2011;29:280–286.277. Renic M, Klaus JA, Omura T, Kawashima N, Onishi M, Miyata N, KoehlerRC, Harder DR, Roman RJ. Effect of 20-HETE inhibition on infarct volume andcerebral blood flow after transient middle cerebral artery occlusion. J. Cereb.Blood Flow Metab. 2009; 29: 629–639.278. Riazi K, Galic MA, Kuzmiski JB, Ho W, Sharkey KA, Pittman QJ.Microglial acti- vation and TNFalpha production mediate altered CNS excitabilityfollowing peripheral inflammation. Proc Natl Acad Sci USA 2008; 105: 17151–17156.279. Rigó JJ., Boze T., Derzsy Z., Derzbach L., Treszl A., Lázár L., Sobel G.,Vásárhelyi B.
Family history of early-onset cardiovascular disorders is associatedwith a higher risk of severe preeclampsia. Eur J Obstet Gynecol Reprod Biol 2006;128(1-2): 148-51.280. Riskin-Mashiah S., Belfort M.A. Preeclampsia is associated with globalcerebral hemodynamic changes. J. Soc. Gynecol. Investig. 2005; 12: 253–256.281. Roberts JM, Gammill HS. Preeclampsia: recent insights.
Hypertension.2005;46:1243–49.282. Roberts JM. Pathophysiology of ischemic placental disease. SeminPerinatol. 2014 Apr;38(3):139-145.283. Rosenberg VA, Buhimschi IA, Lockwood CJ, Paidas MJ, Dulay AT,Ramma W, Abdel-Razeq SS, Zhao G, Ahmad S, Ahmed A, Buhimschi CS.Heparin elevates circulating soluble fms-like tyrosine kinase-1 immunoreactivity340in pregnant women receiving anticoagulation therapy. Circulation.
2011 Dec 6;124(23): 2543-53.284. Ryan MJ, Gilbert EL, Glover PH, George EM, Masterson CW, McLemoreGR Jr, LaMarca B, Granger JP, Drummond HA. Placental ischemia impairs middlecerebral artery myogenic responses in the pregnant rat. Hypertension. 2011 Dec;58(6): 1126-31.285. Sagol S, Ozkinay E, Oztekin K, Ozdemir N. The comparison of uterineartery Doppler velocimetry with the histopathology of the placental bed. Aust N ZJ Obstet Gynaecol. 1999; 39: 324–329.286. Santner-Nanan B, Peek M, Khanam R, Richart L, Zhu E, Fazekas de St G,Nanan R.
Systemic increase in the ration between FoxP3+ and IL-17 producingCD4+ T cells in healthy pregnancy but not in preeclampsia. Journal ofImmunology. 2009;183:7023–7030.287. Savasan ZA, Goncalves LF, Bahado-Singh RO. Second- and third-trimesterbiochemical and ultrasound markers predictive of ischemic placental disease.Semin Perinatol. 2014 Apr;38(3):167-176.288. Schreurs M, Houston E, May V, Cipolla MJ. The adaptation of the bloodbrain barrier to VEGF and PLGF during pregnancy.
FASEB J 2012; 26: 355–362.289. Sezer SD, Küçük M, Yenisey C, Yüksel H, Odabaşı AR, Türkmen MK,Çetinkaya Çakmak B, Ömürlü IK. Comparison of angiogenic and anti-angiogenicfactors in maternal and umbilical cord blood in early-and late-onset pre-eclampsia.Gynecol Endocrinol. 2012 Aug;28(8):628-32.290. Shaker OG, Shehata H. Early prediction of preeclampsia in high-riskwomen. J Womens Health (Larchmt). 2011 Apr;20(4):539-44.291.
Shamshirsaz AA, Paidas M, Krikun G. Preeclampsia, hypoxia, andinflammation. Journal of Pregnancy. 2012;2012:6 pages.374047.292. Sharma A, Satyam A, Sharma JB. Leptin, IL-10 and inflammatory markers(TNF-α, IL-6 and IL-8) in pre-eclamptic, normotensive pregnant and healthy nonpregnant women. American Journal of Reproductive Immunology. 2007;58(1):21–30.341293.
Sherman RW, Bowie RA, Henfrey MME, Mahajan RP, Bogod D. Cerebralhaemodynamics in pregnancy and pre-eclampsia as assessed by transcranialDoppler ultrasonography. Br Journal Anaesth 2002; 89: 687–692.294. Sibai BM. Diagnosis, prevention, and management of eclampsia. ObstetGynecol. 2005 Feb;105(2):402-10.295.
Sifakis S, Akolekar R, Kappou D, Mantas N, Nicolaides KH. Maternalserum insulin-like growth factor-I at 11–13 weeks in preeclampsia. Prenat Diagn.2010;30:1026–1031.296. Sifakis S, Akolekar R, Kappou D, Mantas N, Nicolaides KH. Maternalserum insulin-like growth factor-binding protein-1 (IGFBP-1) at 11–13 weeks inpre-eclampsia. Prenat Diagn. 2011;31:196–201.297. Sifakis S, Akolekar R, Kappou D, Mantas N, Nicolaides KH. Maternalserum insulin-like growth factor-binding protein-3 (IGFBP-3) at 11–13 weeks inpreeclampsia. J Hum Hypertens. 2012;26:253–258.298.
Sifakis S, Akolekar R, Mantas N, Kappou D, Nicolaides KH. Maternalserum human placental growth hormone (hPGH) at 11 to13 weeks of gestation inpreeclampsia. Hypertens Pregnancy. 2011;30:74–82.299. Sifakis S, Koukou Z, Spandidos DA. Cell-free fetal DNA and pregnancyrelated complications (review). Mol Med Rep. 2015 Apr;11(4):2367-72.300. Sipos PI, Rens W, Schlecht H, Fan X, Wareing M, Hayward C, Hubel CA,Bourque S, Baker PN, Davidge ST, Sibley CP, Crocker IP.
Uterine vasculatureremodeling in human pregnancy involves functional macrochimerism byendothelial colony forming cells of fetal origin. Stem Cells. 2013 Jul;31(7):136370.301. Smith GC, Stenhouse EJ, Crossley JA, Aitken DA, Cameron AD, ConnorJM. Early pregnancy levels of pregnancy-associated plasma protein a and the riskof intrauterine growth restriction, premature birth, preeclampsia, and stillbirth. JВClin Endocrinol Metab.
2002 Apr;87(4):1762-1767.302. Smith SD, Dunk CE, Aplin JD. Evidence for immune cell involvement indecidual spiral arteriole remodeling in early human pregnancy. Am J Pathol. 2009;342174: 1959-71.303. Sobel ML, Kingdom J, Drewlo S. Angiogenic response of placental villi toheparin. Obstet Gynecol. 2011 Jun;117(6):1375-83.304. Sonneveld MJ1, Brussé IA, Duvekot JJ, Steegers EA, Grune F, Visser GH.Cerebral perfusion pressure in women with preeclampsia is elevated even aftertreatment of elevated blood pressure. Acta Obstet Gynecol Scand. 2014May;93(5):508-11.305. Soto E, Romero R, Kusanovic JP, Ogge G, Hussein Y, Yeo L, Hassan SS,Kim CJ, ChaiworapongsaT. Late-onset preeclampsia is associated with animbalance of angiogenic and anti-angiogenic factors in patients with and withoutplacental lesions consistent with maternal underperfusion J Matern Fetal NeonatalMed.
2012 May; 25(5): 498-507.306. Spargo B. The renal lesions in preeclampsia. Hypertension in Pregnancy.1976: 129–137..307. Spencer K, Cowans NJ, Nicolaides KH. Low levels of maternal serumPAPP-A in the first trimester and the risk of pre-eclampsia. Prenat Diagn. 2008Jan;28(1):7-10.308. Spencer K, Cowans NJ, Nicolaides KH. Maternal serum inhibin-A andactivin-A levels in the first trimester of pregnancies developing pre-eclampsia.Ultrasound Obstet Gynecol.
2008;32:622–626.309. Spencer K, Yu CK, Cowans NJ, Otigbah C, Nicolaides KH. Prediction ofpregnancy complications by first-trimester maternal serum PAPP-A and free betahCG and with second-trimester uterine artery Doppler. Prenat Diagn. 2005Oct;25(10):949-953.310. Spinillo A, Fazzi E, Stronati M, Ometto A, Iasci A, Guaschino S. Severity ofabruptio placentae and neurodevelopmental outcome in low birth weight infants.Early Hum Dev. 1993;35:45–54.311. Staboulidou I, Galindo A, Maiz N, Karagiannis G, Nicolaides KH. Firsttrimester uterine artery Doppler and serum pregnancy-associated plasma protein-Ain preeclampsia and chromosomal defects. Fetal Diagn Ther. 2009;25:336–339.343312.
Staff AC, Dechend R, Pijnenborg R. Learning from the placenta acuteatherosis and vascular remodelingin preeclampsia — novel aspects foratherosclerosis and future cardiovascular health. Hypertension. 2010;56(6):1026–1034.313. Staff AC, Dechend R, Redman CW. Review: preeclampsia, acute atherosisof the spiral arteries and future cardiovascular disease: two new hypotheses.Placenta. 2013;34 Suppl:S73–8.314.
Staff AC, Johnsen GM, Dechend R, Redman CW. Preeclampsia anduteroplacental acute atherosis: immune and inflammatory factors. J ReprodImmunol. 2014;101-102:120–6.315. Stamilio DM, Sehdev HM, Morgan MA, Propert K, Macones GA. Canantenatal clinical and biochemical markers predict the development of severepreeclampsia? Am J Obstet Gynecol. 2000;182:589–594.316. Staykov D, Schwab S. Posterior reversible encephalopathy syndrome.Nervenarzt. 2012 Aug;83(8):1013-20.317. Steegers EA, von Dadelszen P, Duvekot JJ, Pijnenborg R.
Pre-eclampsia.Lancet. 2010 Aug 21;376(9741):631-44.318. Stillman I.E., Karumanchi S.A. The glomerular injury of preeclampsia. JAm Soc Nephrol. 2007 Aug;18(8): 2281-4.319. Stubert J, Ullmann S, Dieterich M, Diedrich D, Reimer T. Clinicaldifferences between early- and late-onset severe preeclampsia and analysis ofpredictors for perinatal outcome. J Perinat Med. 2014 Sep;42(5):617-27.320.
Su YN, Lee CN, Cheng WF, Shau WY, Chow SN, Hsieh FJ. Decreasedmaternal serum placenta growth factor in early second trimester and preeclampsia.Obstet Gynecol. 2001;97:898–904.321. Swarup J., Balkundi D., Sobchak Brozanski B., Roberts J.M., Yanowitz T.D.Effect of preeclampsia on blood pressure in newborn very low birth weight infants.Hypertens Pregnancy 2005;24(3):223-34.344322. Szarka A, Rigó J, Lázár L, Beko G, Molvarec A. Circulating cytokines,chemokines and adhesion molecules in normal pregnancy and preeclampsiadetermined by multiplex suspension array.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
